Skip to main content
. 2017 Feb 20;13:139–149. doi: 10.2147/TCRM.S124621

Figure 2.

Figure 2

Effect of orlistat on serum periostin level in obese nonalcoholic fatty liver disease patients.

Notes: There was no significant group difference in pretreatment serum periostin levels (P>0.05). *P<0.05, value significantly different from baseline value. **P<0.05, value significantly different between groups.